Chapel hill.

PositionTriangle

CHAPEL HILL--Cempra raised about $25 million in a private stock sale and plans to use the proceeds for general corporate purposes and to pay for clinical trials. The company develops drugs that treat...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT